Held Daniel M, Kissel Jay D, Saran Dayal, Michalowski Daniel, Burke Donald H
Department of Biology, Indiana University, Bloomington, Indiana 47405, USA.
J Biol Chem. 2006 Sep 1;281(35):25712-22. doi: 10.1074/jbc.M604460200. Epub 2006 Jun 23.
Nucleic acid aptamers to HIV-1 reverse transcriptase (RT) are potent inhibitors of DNA polymerase function in vitro, and they have been shown to inhibit viral replication when expressed in cultured T-lymphoid lines. We monitored RT inhibition by five RNA pseudoknot RNA aptamers in a series of biochemical assays designed to mimic discrete steps of viral reverse transcription. Our results demonstrate potent aptamer inhibition (IC50 values in the low nanomolar range) of all RT functions assayed, including RNA- and DNA-primed DNA polymerization, strand displacement synthesis, and polymerase-independent RNase H activity. Additionally, we observe differences in the time dependence of aptamer inhibition. Polymerase-independent RNase H activity is the most resistant to long term aptamer suppression, and RNA-dependent DNA polymerization is the most susceptible. Finally, when DNA polymerization was monitored in the presence of an RNA aptamer in combination with each of four different small molecule inhibitors, significant synergy was observed between the aptamer and the two nucleoside analog RT inhibitors (azidothymidine triphosphate or ddCTP), whereas two non-nucleoside analog RT inhibitors showed either weak synergy (efavirenz) or antagonism (nevirapine). Together, these results support a model wherein aptamers suppress viral replication by cumulative inhibition of RT at every stage of genome replication.
针对HIV-1逆转录酶(RT)的核酸适配体在体外是DNA聚合酶功能的有效抑制剂,并且已证明当在培养的T淋巴细胞系中表达时,它们可抑制病毒复制。我们在一系列旨在模拟病毒逆转录离散步骤的生化试验中监测了五种RNA假结RNA适配体对RT的抑制作用。我们的结果表明,所检测的所有RT功能(包括RNA引发和DNA引发的DNA聚合、链置换合成以及不依赖聚合酶的RNase H活性)均受到适配体的有效抑制(IC50值在低纳摩尔范围内)。此外,我们观察到适配体抑制的时间依赖性存在差异。不依赖聚合酶的RNase H活性对长期适配体抑制最具抗性,而RNA依赖性DNA聚合最敏感。最后,当在RNA适配体与四种不同小分子抑制剂中的每一种共同存在的情况下监测DNA聚合时,在适配体与两种核苷类似物RT抑制剂(叠氮胸苷三磷酸或ddCTP)之间观察到显著的协同作用,而两种非核苷类似物RT抑制剂则表现出弱协同作用(依非韦伦)或拮抗作用(奈韦拉平)。总之,这些结果支持了一种模型,即适配体通过在基因组复制的每个阶段对RT的累积抑制来抑制病毒复制。